| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.20B | 33.63B | 21.64B | 17.68B | 22.87B | 17.27B |
| Gross Profit | 8.43B | 7.22B | 5.05B | 5.75B | 3.12B | 3.02B |
| EBITDA | 7.85B | 7.79B | 6.59B | 5.11B | 3.52B | 3.30B |
| Net Income | 3.53B | 3.40B | 3.04B | 2.66B | 1.72B | 1.50B |
Balance Sheet | ||||||
| Total Assets | 68.20B | 66.64B | 64.07B | 44.27B | 24.38B | 23.62B |
| Cash, Cash Equivalents and Short-Term Investments | 172.00M | 78.00M | 733.00M | 338.00M | 220.00M | 146.39M |
| Total Debt | 33.65B | 32.82B | 32.29B | 21.76B | 13.70B | 13.73B |
| Total Liabilities | 45.76B | 44.07B | 41.94B | 27.78B | 17.89B | 17.61B |
| Stockholders Equity | 22.36B | 22.48B | 17.04B | 16.48B | 6.49B | 6.02B |
Cash Flow | ||||||
| Free Cash Flow | 2.24B | 2.45B | 2.87B | 2.83B | 1.70B | 1.85B |
| Operating Cash Flow | 5.63B | 5.60B | 4.89B | 4.42B | 2.91B | 2.55B |
| Investing Cash Flow | -4.06B | -3.75B | -6.61B | -6.40B | -1.14B | -665.29M |
| Financing Cash Flow | -1.53B | -2.50B | 2.12B | 2.10B | -1.69B | -2.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $74.73B | 19.11 | 10.69% | 4.27% | 12.38% | 28.17% | |
73 Outperform | $85.22B | 13.95 | 20.04% | 6.72% | -9.49% | 1.01% | |
73 Outperform | $56.26B | 15.91 | 33.27% | 7.31% | 3.18% | 6.43% | |
72 Outperform | $58.06B | 18.41 | 15.92% | 5.61% | 41.04% | 9.18% | |
71 Outperform | $58.10B | 28.10 | 73.92% | 2.03% | -1.23% | 80.28% | |
70 Outperform | $95.25B | 24.40 | 22.37% | 3.35% | 9.99% | 22.02% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |